Topical Pain Relief Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2028

The global topical pain relief market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period (2022-2028). The rising prevalence of arthritis in many regions of the world has led to a surge in demand for topical pain relievers. Companies in the worldwide topical pain relief market will be able to generate income as a result of this factor. Additionally, the industry is expected to gain promising pathways as the number of people living with additional joint diseases rises. Different bone-related disorders are more common in the elderly population. As a result, the global expansion in this population is likely to benefit the growth of the topical pain relief market over the forecast period. In recent years, there has been a dramatic increase in public knowledge of non-opioid side effects. Furthermore, the number of persons suffering from chronic pain is rising. These factors are propelling the global topical pain relief market forward. For instance, in 2021, AdvaCare offers Diclofenac cream is a nonsteroidal anti-inflammatory medication used to treat pain and other symptoms of arthritis of the joints (e.g. osteoarthritis), such as inflammation, swelling, stiffness, and joint pain. Diclofenac cream is a topical solution used to treat pain and swelling caused by osteoarthritis of the knees. For instance, in 2020 FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the US. It is a combination of ibuprofen and acetaminophen for pain relief, the benefits of both active ingredients when safely treating their headaches, muscle aches, backaches, arthritis, and other joint pain.

To Request a Sample of our Report on Topical Pain Relief Market: https://www.omrglobal.com/request-sample/topical-pain-relief-gel-market-share

Market Coverage

· The market number available for - 2021-2028

· Base year- 2021

· Forecast period- 2022-2028

Segment Covered-

· By Formulation

· By Distribution Channel

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- including AdvaCare Pharma, Cipla Health Ltd., Exzell Pharma, GlaxoSmithKline Plc. Novartis AG, and Others.

(Get 15% Discount on Buying this Report)

A full Report of Topical Pain Relief Market is Available @ https://www.omrglobal.com/industry-reports/topical-pain-relief-gel-market-share

Global Topical pain Relief Market Report Segment

By Formulation

· Cream

· Gel

· Spray

· Others (Patch)

By Distribution Channel

· Online

· Offline

Global Topical Pain Relief Market Report Segment by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Company Profiles

· Amrutanjan Health Care Ltd.

· Green Cure Wellness

· Hemma Herbs Pvt. Ltd.

· Himalaya Wellness Co.

· Johnson & Johnson Consumer Inc.

· Nestle S.A.

· Pfizer Inc.

· Reckitt Benckiser Group Plc.

· Sanofi S.A.

· Strides Consumer, LLC.

· Sun Pharmaceutical Industries Ltd.

· The Mentholatum Co. Ltd.

· Topical BioMedics, Inc.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.